Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,936 public trials 460 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis

NCT02576717

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Local Institution - 115 Phoenix, Arizona, United States
  • Local Institution - 118 Phoenix, Arizona, United States
  • Local Institution - 110 Berkeley, California, United States
  • Local Institution - 103 Fresno, California, United States
View all 175 locations
View Trial Details
Completed

At-Home Gait Assessment

NCT05724901

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • NYU Langone Health New York, United States
View Trial Details
Completed

Safety of Exposure to Natalizumab During Pregnancy

NCT05209815

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • CHRU de Besançon - service de neurologie Besançon, France
  • CHU de Bordeaux - service de neurologie Bordeaux, France
  • HCL - service de neurologie Bron, France
  • CH Sud Francilien - service de neurologie Corbeil-Essonnes, France
View all 27 locations
View Trial Details
Completed

Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome

NCT01817166

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • CHU d'Amiens - Hôpital Nord Amiens, France
  • CHU de Lyon - Hôpital Pierre Wertheimer Bron, France
  • CHU de Caen - Hôpital Côte de Nacre Caen, France
  • CHU de Clermont Ferrand - Hôpital Gabriel-Montpied Clermont-Ferrand, France
View all 33 locations
View Trial Details
Completed

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

NCT01194570

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Phoenix Neurological Associates Ltd Phoenix, Arizona, United States
  • Barrow Neurology Clinic Phoenix, Arizona, United States
  • Mayo Clinic- Scottsdale Scottsdale, Arizona, United States
  • Arizona Neuroscience Research LLC Phoenix, Arkansas, United States
View all 184 locations
View Trial Details

Related conditions